Table 4 Maintenance therapy containing 5FU/LV.
From: Feasibility of alternating induction and maintenance chemotherapy in pancreatic cancer
Characteristic | |
|---|---|
Patients | 13 |
Treatment cycles, total | 97 |
Treatment cycles, median (range) | 6 (2–21) |
Cycles with | |
Dose reduction | 9 (9%) |
Treatment delay ≥1 week | 16 (16%) |
Treatment time, median (range) | 14.1 weeks (4–54.1) |
